Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The stratum corneum keratin and associated corneocyte cohesion structures, primarily corneodesmosomes, represent the fundamental structural framework of the skin's outermost layer. Keratins, specifically Keratin 1 and Keratin 10, form a dense intermediate filament network within corneocytes, providing mechanical resilience and contributing to the skin's barrier properties (StatPearls: Physiology, Stratum Corneum). Corneodesmosomes are specialized intercellular junctions that anchor corneocytes together, and their timely degradation by proteases like kallikreins is essential for normal desquamation (PubMed: Corneodesmosomes: structure, function and importance in skin diseases). In pathological states such as psoriasis or ichthyosis, these structures are often overproduced or fail to degrade properly, leading to hyperkeratosis and scaling (NIH: Ichthyosis). Pharmacological intervention typically involves keratolytic agents like salicylic acid or urea, which disrupt the cohesive forces between corneocytes or soften the keratin matrix to facilitate shedding (PubMed: Keratolytic agents in dermatology). These targets are central to dermatological therapy aimed at restoring barrier function and treating proliferative skin disorders. Additionally, retinoids can modulate the expression of these structural proteins to normalize skin turnover. Understanding the biochemical composition of these structures is crucial for developing targeted therapies for barrier-related diseases.
Keratolytic agents promote the dissolution of the intercellular cement (corneodesmosomes) and the denaturation of keratin, leading to increased desquamation and thinning of the stratum corneum (PubMed: Keratolytic agents in dermatology).
6 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Stratum corneum keratin and corneodesmosome.